Janus Henderson Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $557K | Hold |
23,319
| – | – | ﹤0.01% | 1893 |
|
2025
Q1 | $581K | Hold |
23,319
| – | – | ﹤0.01% | 1877 |
|
2024
Q4 | $439K | Hold |
23,319
| – | – | ﹤0.01% | 2094 |
|
2024
Q3 | $351K | Sell |
23,319
-675,069
| -97% | -$10.2M | ﹤0.01% | 2191 |
|
2024
Q2 | $20M | Buy |
698,388
+96,328
| +16% | +$2.76M | 0.01% | 570 |
|
2024
Q1 | $17.6M | Sell |
602,060
-1,973
| -0.3% | -$57.7K | 0.01% | 582 |
|
2023
Q4 | $20.4M | Buy |
604,033
+66,330
| +12% | +$2.24M | 0.01% | 547 |
|
2023
Q3 | $16.5M | Buy |
537,703
+183,604
| +52% | +$5.63M | 0.01% | 571 |
|
2023
Q2 | $14.2M | Buy |
354,099
+334,292
| +1,688% | +$13.4M | 0.01% | 622 |
|
2023
Q1 | $808K | Buy |
19,807
+10,976
| +124% | +$448K | ﹤0.01% | 1745 |
|
2022
Q4 | $341K | Buy |
8,831
+1
| +0% | +$39 | ﹤0.01% | 1917 |
|
2022
Q3 | $470K | Buy |
8,830
+16
| +0.2% | +$852 | ﹤0.01% | 1982 |
|
2022
Q2 | $514K | Sell |
8,814
-9
| -0.1% | -$525 | ﹤0.01% | 1746 |
|
2022
Q1 | $674K | Sell |
8,823
-30,842
| -78% | -$2.36M | ﹤0.01% | 1722 |
|
2021
Q4 | $2.39M | Sell |
39,665
-22,278
| -36% | -$1.34M | ﹤0.01% | 1220 |
|
2021
Q3 | $3.47M | Sell |
61,943
-10,391
| -14% | -$582K | ﹤0.01% | 1142 |
|
2021
Q2 | $4.39M | Sell |
72,334
-4,981
| -6% | -$302K | ﹤0.01% | 1089 |
|
2021
Q1 | $5.42M | Buy |
+77,315
| New | +$5.42M | ﹤0.01% | 997 |
|
2016
Q1 | – | Sell |
-159,210
| Closed | -$12.2M | – | 846 |
|
2015
Q4 | $12.2M | Buy |
159,210
+25,708
| +19% | +$1.97M | 0.1% | 232 |
|
2015
Q3 | $5.49M | Buy |
133,502
+25,990
| +24% | +$1.07M | 0.05% | 330 |
|
2015
Q2 | $7.6M | Buy |
107,512
+9,612
| +10% | +$680K | 0.06% | 304 |
|
2015
Q1 | $8.7M | Buy |
97,900
+32,430
| +50% | +$2.88M | 0.07% | 302 |
|
2014
Q4 | $5.81M | Buy |
65,470
+11,578
| +21% | +$1.03M | 0.04% | 349 |
|
2014
Q3 | $5.22M | Buy |
+53,892
| New | +$5.22M | 0.05% | 267 |
|